XML 14 R21.htm IDEA: XBRL DOCUMENT
v3.19.3

Net Loss per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2019
Net Loss per Share |
Schedule of computation of diluted net loss per weighted average number of shares outstanding | The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics, Inc. and Subsidiaries for the three and nine months ended September 30, 2019 and 2018 (in thousands except share and per share amounts):
|  | Three months ended September 30, 2019 |  | Nine months ended September 30, 2019
|  | Net loss |  | Shares |  | Per Share |  | Net Loss |  | Shares |  | Per Share
|  | (Numerator) |  | (Denominator) |  | Amount |  | (Numerator) |  | (Denominator) |  | Amount
Net loss - Basic |  | $ | (5,253) |  | 16,805,257 |  | $ | (0.31) |  | $ | (12,934) |  | 16,313,326 |  | $ | (0.79)
Dilutive shares related to warrants |  |  | — |  | — |  |  | — |  |  | — |  | — |  |  | —
Net loss - Dilutive |  | $ | (5,253) |  | 16,805,257 |  | $ | (0.31) |  | $ | (12,934) |  | 16,313,326 |  | $ | (0.79)
|  | Three months ended September 30, 2018 |  | Nine months ended September 30, 2018
|  | Net loss |  | Shares |  | Per Share |  | Net Loss |  | Shares |  | Per Share
|  | (Numerator) |  | (Denominator) |  | Amount |  | (Numerator) |  | (Denominator) |  | Amount
Net loss - Basic |  | $ | (3,741) |  | 4,028,304 |  | $ | (0.93) |  | $ | (10,375) |  | 3,802,812 |  | $ | (2.73)
Dilutive shares related to warrants |  |  | — |  | — |  |  | — |  |  | — |  | — |  |  | —
Net loss - Dilutive |  | $ | (3,741) |  | 4,028,304 |  | $ | (0.93) |  | $ | (10,375) |  | 3,802,812 |  | $ | (2.73)

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration